Connective tissue proteins

Connective tissue proteins are a diverse group of extracellular matrix (ECM) components that provide the essential structural framework and mechanical properties for tissues throughout the body. This category encompasses major proteins such as collagens, which provide tensile strength; elastin, which confers resilience and recoil; and glycoproteins like fibronectin and laminin, which facilitate cell-matrix interactions (Source: StatPearls, Histology, Connective Tissue). These proteins play critical roles in maintaining tissue architecture, regulating cell migration, and mediating signal transduction. Pathological alterations in the synthesis or degradation of connective tissue proteins are linked to a wide range of diseases, including systemic sclerosis, pulmonary fibrosis, and genetic disorders like Marfan syndrome (Source: NIH, Connective Tissue Diseases). In cancer, the remodeling of these proteins often facilitates tumor invasion and metastasis. While specific proteins within this group are targeted by drugs—such as collagenase for treating Dupuytren's contracture—the term Connective tissue proteins is a broad classification rather than a single therapeutic target (Source: PubChem). Therapeutic interventions typically focus on inhibiting the excessive deposition of these proteins in fibrotic conditions or promoting their repair in degenerative diseases. Consequently, this group is of high interest in regenerative medicine and oncology.

Other names

Extracellular matrix proteinsECM proteinsStructural proteins of the connective tissue

Enzymatic degradation of specific extracellular matrix components to resolve pathological accumulation or facilitate tissue remodeling.